Proceedings of the GRAPPA 2022 Executive Retreat

Beverly Cheok Kuan Ng; Deepak Jadon; Adewale Adebajo; Gizem Ayan; Kristina Callis Duffin; Vinod Chandran; Laura C Coates; Maria Antonietta D'Agostino; Kurt de Vlam; Atul Deodhar; Lihi Eder; Amit Garg; Dafna D Gladman; Niti Goel; Alice B Gottlieb; M Elaine Husni; Arnon Katz; Arthur Kavanaugh; Ennio Lubrano; Philip J Mease; Joseph F Merola; Peter Nash; Alexis Ogdie; Stephen R Pennington; Lourdes M Perez-Chada; Fabian Proft; Cheryl F Rosen; Laura Savage; Claudia Goldenstein-Schainberg; Stefan Siebert; Enrique R Soriano; Ingrid Steinkoenig; William Tillett; April W Armstrong; Oliver FitzGerald

doi:10.3899/jrheum.2023-0537

Proceedings of the GRAPPA 2022 Executive Retreat

J Rheumatol. 2023 Nov;50(Suppl 2):71-77. doi: 10.3899/jrheum.2023-0537. Epub 2023 Aug 1.

Authors

Beverly Cheok Kuan Ng¹, Deepak Jadon¹, Adewale Adebajo², Gizem Ayan³, Kristina Callis Duffin⁴, Vinod Chandran⁵, Laura C Coates⁶, Maria Antonietta D'Agostino⁷, Kurt de Vlam⁸, Atul Deodhar⁹, Lihi Eder¹⁰, Amit Garg¹¹, Dafna D Gladman¹², Niti Goel¹³, Alice B Gottlieb¹⁴, M Elaine Husni¹⁵, Arnon Katz¹⁶, Arthur Kavanaugh¹⁷, Ennio Lubrano¹⁸, Philip J Mease¹⁹, Joseph F Merola²⁰, Peter Nash²¹, Alexis Ogdie²², Stephen R Pennington²³, Lourdes M Perez-Chada²⁴, Fabian Proft²⁵, Cheryl F Rosen²⁶, Laura Savage²⁷, Claudia Goldenstein-Schainberg²⁸, Stefan Siebert²⁹, Enrique R Soriano³⁰, Ingrid Steinkoenig³¹, William Tillett³², April W Armstrong³³, Oliver FitzGerald³⁴

Affiliations

¹ B.C.K. Ng, MBBS, MSc, D. Jadon, MBBCh, PhD, Rheumatology Research Unit, Department of Medicine, University of Cambridge, Cambridge, UK.
² A. Adebajo, MD, MBE, Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, UK.
³ G. Ayan, MD, Division of Rheumatology, Department of Internal Medicine, Hacettepe University Medical Faculty, Ankara, Turkey.
⁴ K. Callis Duffin, MD, MS, Department of Dermatology, University of Utah, Salt Lake City, Utah, USA.
⁵ V. Chandran, MD, DM, PhD, Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, and Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Canada.
⁶ L.C. Coates, MD, PhD, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
⁷ M.A. D'Agostino, MD, PhD, Catholic University of the Sacred Heart, Milan, Italy.
⁸ K. de Vlam, MD, PhD, University Hospitals Leuven, Leuven, Belgium.
⁹ A. Deodhar, MD, Division of Arthritis and Rheumatic Diseases, Oregon Health & Science University, Portland, Oregon, USA.
¹⁰ L. Eder, MD, PhD, Women's College Research Institute and University of Toronto, Toronto, Ontario, Canada.
¹¹ A. Garg, MD, Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra Northwell, Hempstead, New York, USA.
¹² D.D. Gladman, MD, Division of Rheumatology, Department of Medicine, University of Toronto, Toronto, Canada.
¹³ N. Goel, MD, Patient Research Partner, Division of Rheumatology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
¹⁴ A.B. Gottlieb, MD, PhD, Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
¹⁵ M.E. Husni, MD, MPH, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic, Cleveland, Ohio, USA.
¹⁶ A. Katz, MSc, Technion Israel Institute of Technology, Haifa, Israel.
¹⁷ A. Kavanaugh, MD, Division of Rheumatology, Allergy, and Immunology, University of California San Diego, La Jolla, California, USA.
¹⁸ E. Lubrano, MD, PhD, Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy.
¹⁹ P.J. Mease, MD, Rheumatology Research, Swedish Medical Center and University of Washington, Seattle, Washington, USA.
²⁰ J.F. Merola, MD, MMSc, Department of Dermatology and Department of Medicine, Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
²¹ P. Nash, MBBS, MD, School of Medicine, Griffith University, Brisbane, Australia.
²² A. Ogdie, MD, MSCE, Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
²³ S.R. Pennington, PhD, O. FitzGerald, MBBCh, MD, School of Medicine, and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.
²⁴ L.M. Perez-Chada, MD, MMSc, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
²⁵ F. Proft, MD, Department of Gastroenterology, Infectiology and Rheumatology (including Nutrition Medicine), Charité - Universitätsmedizin Berlin, Berlin, Germany.
²⁶ C.F. Rosen, MD, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
²⁷ L. Savage, MBChB, PhD, Department of Dermatology, University of Leeds, Leeds, UK.
²⁸ C. Goldenstein-Schainberg, MD, PhD, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
²⁹ S. Siebert, MD, School of Infection and Immunity, University of Glasgow, Glasgow, UK.
³⁰ E.R. Soriano, MD, MS, University Institute and Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
³¹ I. Steinkoenig, Cleveland Clinic, Cleveland, Ohio, USA.
³² W. Tillet, MBChB, PhD, Department of Life Sciences, Centre for Therapeutic Innovation, Royal National Hospital for Rheumatic Diseases, Bath, UK.
³³ A.W. Armstrong, MD, MPH, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
³⁴ S.R. Pennington, PhD, O. FitzGerald, MBBCh, MD, School of Medicine, and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; oliver.fitzgerald@ucd.ie.

PMID: 37527861
DOI: 10.3899/jrheum.2023-0537

Abstract

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) leadership congregated for a strategic planning meeting before the 2022 GRAPPA annual meeting in New York, USA. Meeting aims were to review GRAPPA's performance in relation to its 2016 goals and identify successes and areas for further improvement, identify key GRAPPA priorities and activities for the next 5 years, and explore committee structures to best support these aims.

Keywords: GRAPPA; arthritis; education; psoriasis; psoriatic arthritis; research.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Arthritis, Psoriatic*
Dermatology*
Humans
Psoriasis*
Rheumatology*